Oral Glucagon-Like Peptide 1 Analog as an Adjuvant Therapy in Generalized Lipodystrophy [0.03%]
在全身性脂质异位症的辅助治疗中使用的口服胰高血糖素类肽1类似物
Yael Lebenthal,Sharon Halperin,Hagar Interator et al.
Yael Lebenthal et al.
Early Fasting Serum Glucose or Weight Reduction With Tirzepatide and Metabolic Outcomes in People With Type 2 Diabetes: A Post Hoc Analysis of the SURPASS Trials [0.03%]
曲格列肽对2型糖尿病患者早期空腹血糖或体重下降及代谢结果的影响：SURPASS试验的回顾性分析
Francesco Giorgino,Ildiko Lingvay,Luc F Van Gaal et al.
Francesco Giorgino et al.
Objective: To evaluate late (week 40 or 42; hereafter, week 40/42) metabolic outcomes by early glycemic response (
Modeling Cardiovascular Protection With SGLT Inhibition in Type 1 Diabetes: A Risk-Based Approach to Guide Therapy? [0.03%]
SGLT抑制在1型糖尿病中对心血管保护作用的建模：基于风险的方法指导治疗？
Luxcia Kugathasan,Pritha Dutta,Massimo Nardone et al.
Luxcia Kugathasan et al.
Use of Medical Identification for People Living With Type 1 Diabetes: Results From the BETTER Registry [0.03%]
患有1型糖尿病人群医疗识别的使用情况：BETTER注册中心的结果
Virginie Messier,Anne-Sophie Brazeau,Maha Lebbar et al.
Virginie Messier et al.
Progression of Cerebral Small Vessel Disease Among Neurologically Asymptomatic Middle-Aged Individuals With Type 1 Diabetes [0.03%]
I型糖尿病神经无症状中年人的脑小血管病变进展研究
Aleksi Tarkkonen,Iiris Kyläheiko,Jussi Inkeri et al.
Aleksi Tarkkonen et al.
Objective: To investigate the potential progression rate of cerebral small vessel disease (CSVD) in brain MRI among neurologically asymptomatic middle-aged individuals with type 1 diabetes. ...
Tiffany Tian,Cindy N Ho,Alessandra T Ayers et al.
Tiffany Tian et al.
Objective: Diabetes devices, including continuous glucose monitors (CGMs) and insulin pumps, may significantly affect environmental sustainability and long-term resilience. ...
Effect of Oral Semaglutide Versus Comparators on Multiple Cardiometabolic Risk Factor Control in Adults With Type 2 Diabetes [0.03%]
司美格鲁肽对比其他药物对2型糖尿病成人多重心血管代谢危险因素控制的影响
Vanita R Aroda,Brian Malling,Juris J Meier et al.
Vanita R Aroda et al.
Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option? [0.03%]
Tirzepatide在脂质萎缩症中的代谢改善作用：一种新型选择？
Rasimcan Meral,Merve Celik Guler,Diarratou Kaba et al.
Rasimcan Meral et al.
Objective: Lipodystrophy encompasses a group of rare disorders associated with severe metabolic disease. These disorders are defined by abnormal fat distribution, with near-total (generalized lipodystrophy [GL]) or partia...
One-Hour Oral Glucose Tolerance Test for the Postpartum Reclassification of Women With Hyperglycemia in Pregnancy [0.03%]
产后对妊娠期高血糖妇女进行葡萄糖耐量试验重新分类的方法
Ravi Retnakaran,Chang Ye,Caroline K Kramer et al.
Ravi Retnakaran et al.
Objective: The International Diabetes Federation recently endorsed a 1-h oral glucose tolerance test (OGTT) as more convenient than the conventional 2-h OGTT. In practice, women with hyperglycemia in pregnancy are advised...
Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of Heart Failure and Chronic Kidney Disease [0.03%]
芬克洛酮对二型糖尿病患者的有效性和安全性：心力衰竭和慢性肾病试验的荟萃分析
John W Ostrominski,Brian L Claggett,Zi Michael Miao et al.
John W Ostrominski et al.
Objective: To evaluate the efficacy and safety of finerenone, a nonsteroidal mineralocorticoid receptor antagonist, in individuals with type 2 diabetes (T2D) and either chronic kidney disease (CKD) or heart failure (HF) w...